Pricing Log in Create free account

Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs Iambic Therapeutics, Inc. (IAM)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Iambic Therapeutics, Inc. are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Iambic Therapeutics, Inc. are of similar size ($551.7M and $524.8M).

Valuation

Metric CYVNY IAM Biotechnology median
P/E n/m — 10.60
P/S 2.37 — 9.40
P/B n/m — 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m — 0.66
EV/Sales 759.28 — 9.02
Earnings yield (2,375.00%) — (32.88%)
Free cash flow yield (84,379.36%) — (23.13%)

Profitability

Metric CYVNY IAM Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin (89,724.18%) — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity 0.00% — (51.96%)
Return on assets 0.00% — (46.06%)
Return on invested capital 0.00% — 0.00%

Growth

Metric CYVNY IAM Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 61.59% — 29.88%
Revenue growth, 5-year CAGR (15.81%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CYVNY IAM Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 0.22 — 4.97
Net debt to EBITDA 0.31 — 1.01

Dividend

Metric CYVNY IAM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CYVNY IAM Biotechnology median
Market cap 524.83m 551.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack